|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
14th Floor,New Haven,CT,US
|
|
Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. Trevi is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson's disease. The conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems.
Founded in 2011, Trevi is headquartered in New Haven, CT.
|
Trevi Therapeutics, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
100%
|
The widely used Trevi Therapeutics, Inc. email format is {first}.{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Trevi Therapeutics, Inc. customer service number call here 203-304-2499. To contact Trevi Therapeutics, Inc. customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.